OBJECTIVES: Evaluate long-term rates of virological failure and treatment interruption for people living with HIV (PLWHIV) with viral suppression on first-line efavirenz + tenofovir disoproxil fumarate + emtricitabine/lamivudine (EFV + TDF + FTC/3TC), and compare these according to patient characteristics. METHODS: PLWHIV enrolled in the Collaboration of Observational HIV Epidemiological Research Europe cohort collaboration, who started first-line EFV + TDF + FTC/3TC at age at least 16 years and had viral suppression (<200 copies/ml) within 9 months were included. Rates of virological failure (≥200 copies/ml) and (complete) treatment interruption were estimated according to years since initial suppression. We used Poisson regression to exam...
Objective This study described the demographics, treatment information and identified characteristic...
BACKGROUND: Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-sc...
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strate...
OBJECTIVES: Evaluate long-term rates of virological failure and treatment interruption for people li...
Objectives: Evaluate long-term rates of virological failure and treatment interruption for people li...
Abstract Introduction: Achieving viral suppression is key in the global strategy to end the HIV epid...
Background: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
BACKGROUND: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
Background: We hypothesized that the percent adherence to antiretroviral therapy necessary to mainta...
OBJECTIVE: To investigate predictors of continued HIV RNA viral load suppression in individuals swit...
Ajuts: CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network (Integrated Project no. 223131,...
Objectives : HIV-infected persons experience different patterns of viral suppression after initiatin...
Objective: To assess factors at the start of antiretroviral therapy (ART) associated with long-term ...
Background: Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-sca...
BACKGROUND: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
Objective This study described the demographics, treatment information and identified characteristic...
BACKGROUND: Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-sc...
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strate...
OBJECTIVES: Evaluate long-term rates of virological failure and treatment interruption for people li...
Objectives: Evaluate long-term rates of virological failure and treatment interruption for people li...
Abstract Introduction: Achieving viral suppression is key in the global strategy to end the HIV epid...
Background: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
BACKGROUND: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
Background: We hypothesized that the percent adherence to antiretroviral therapy necessary to mainta...
OBJECTIVE: To investigate predictors of continued HIV RNA viral load suppression in individuals swit...
Ajuts: CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network (Integrated Project no. 223131,...
Objectives : HIV-infected persons experience different patterns of viral suppression after initiatin...
Objective: To assess factors at the start of antiretroviral therapy (ART) associated with long-term ...
Background: Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-sca...
BACKGROUND: Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to ap...
Objective This study described the demographics, treatment information and identified characteristic...
BACKGROUND: Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through wide-sc...
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strate...